Innovating Works

ABAC THERAPEUTICS

Activa
BREAKthrough: Breaking the barrier - An integrated multidisciplinary approach to kill Gram-negative bacteria throu... UNIVERSITE CATHOLIQUE DE LOUVAIN tramitó un HORIZON EUROPE: HORIZON-MSCA-2021-DN-01 Antimicrobial resistance, which is caused by multi-drug-resistant bacterial pathogens is a global health emergency. Gram-negative bacteria (...
2022-07-14 - 2026-12-31 | Financiado
INNOTARGETS: Innvative approaches to identification of metabolic Targets for antimicrobials KOBENHAVNS UNIVERSITET tramitó un H2020: H2020-MSCA-ITN-2020 Antimicrobial resistance (AMR) is a challenge to human health and health-systems, and we need novel antimicrobials or drugs that can re-sens...
2020-08-13 - 2025-11-30 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.